50th Intelligent Sensing Program – Sensing in Precision Medicine and Digital Health
26th March, 9:30am - 4:30pm
Leigh Court
Contact
Leigh Court, Bristol, BS8 3RL
Rapid advances in ‘omic’ technologies and the continued growth of digital health technologies including the use of Artificial Intelligence (AI) have provided clinicians with the unprecedented ability to tailor medical treatment to the individual characteristics of each patient. Understanding patients’ molecular and genetic profiles, give insight into their susceptibility to a particular disease or their response to a specific treatment. This leads to the emergence of a new health care strategy, precision medicine. It will enable more precise diagnosis, more informed clinical decisions and, ultimately, a more targeted and effective treatment or intervention for every patient, improving the overall care quality.
The emergence of precision medicine as a disruptive medical approach has been attracting great interests from health care industries and research communities. Nevertheless, there are significant challenges to overcome before it achieves its full disruptive potential.
In the UK, precision medicine has become a key innovation focus for health care development. Increasingly, cross-board efforts have been applied to progress precision medicine technologies, from government agencies, research communities, to industry companies, and healthcare providers.
The purpose of this workshop is to bring together relevant communities, sensor technology providers, new molecular characterisation technology developers and innovators working in AI, and other relevant stakeholders such as innovation funders. It aims to facilitate knowledge sharing, stimulate new ideas generation, develop new collaborations and partnerships, and promote the innovation development and the adaptation of such sensing technologies in the UK health industries.
Leading experts will discuss key subjects relevant to market challenges and opportunities, state of the art sensing technologies, emerging sensing technologies, as well as relevant innovation funding opportunities in the UK. Agenda will be released closer to the event.
The event will also have exhibition stands for industrial exhibitors interested in showcasing their technologies, expertise, and capabilities to the event participants.
Programme (Subject to Change)
09:30 Arrival & Registration
10:00 Welcome, Knowledge Transfer Network
10:05 Introduction to Knowledge Transfer Network
Market Challenges & Opportunities
10:15 Challenges & Technologies in Precision Medicine
10:45 Digital Health Challenges & Needs
11:15 Refreshment Break & Networking
State of Art Commercial Sensing Technologies
11:45 Making Sense of Data: What AI & ML Can Bring to Digital Health – James Amor, Augmented Insights Ltd
12:15 Digital Phenotypic Markets From Wearable Sensors: Depression & Parkinson’s Disease – Charles Nduka, Emteq Ltd
12:45 Bloodlessly Monitoring Serum Analyses Using Non-Invasive Biosensors – Jack Jachmann, Cambridge Medical Technologies
13:15 Lunch & Networking
Enabling Technologies (Sensing, AI & Omics)
14:15 The Tricorder is Dead – Long Live the Tricorder – Keith Errey , Isansys Lifecare Ltd
14:45 Segmental Microfluidic Sensing Technology for Precision Medicine – Xize Niu , SouthWestSensor Ltd
15:15 Implantable Technology for Medical Care – Anna-Louisa Schaffgotsch, Impli Limited
Relevant Funding Opportunities
15:45 Innovate UK & Relevant Funding Opportunities
16:15 Close & Networking